For comments, suggestions
Created with Raphaël 2.1.0 18.02.2016 Filing date 26.09.2017 Validation fee payment 28.02.2018 (A1) Patent application published 07.11.2019 AGEPI application filing date 31.12.2019 (T2) Translation of the validated European patent 18.02.2024 Valid until 30.11.2024 (MM4E) Forfeiture of rights 01.05.2025 19.08.2025 Renewal fee (with penalties) to be paid until (grace period) 18.02.2036 Patent will expire on

Patent lapsed - still in grace period


(210)Number of the EPO application16706741
(220)Filing date of the EPO application2016.02.18
(80)EPO patent specification publication (B)EPB nr. 38/2019, 2019.09.18
(110)EPO patent number3261720
(11)Number of the documentMD 3261720 T2
(21)Number of the applicatione 2018 0022
(71)Name(s) of applicant(s), code of the countryELI LILLY AND COMPANY, US;
(72)Name(s) of inventor(s), code of the countryALVARADO Alberto, US;
DRIVER David, US;
HAYASHI Mansuo Lu, US;
LU Jirong, US;
(73)Name(s) of owner(s), code of the countryELI LILLY AND COMPANY, US;
(54)Title of the inventionAntibodies to Tau and uses thereof
(13)Kind-of-document code T2
(51)International Patent Classification A61P 25/28 (2006.01.01); A61K 39/00 (2006.01.01); C07K 16/18 (2006.01.01)
(19)CountryUS
(41)Date of publication of the application2018.02.28
(49)Date of publication of the translation of the validated European patent specification2019.12.31
(30)Priority201562121116 P, 2015.02.26, US
(74)Patent attorney(Procedură) PARASCA Dumitru, str. Eminescu nr. 40, ap. 13, c/p 28, MD-2012, Chişinău, Republica Moldova
(86)International applicationPCT/US2016/018419, 2016.02.18
(87)International publicationWO 2016/137811, 2016.09.01
Up
/Inventions/details/3261720